Literature DB >> 24112904

Deep brain stimulation for cognitive disorders.

Adrian W Laxton1, Nir Lipsman, Andres M Lozano.   

Abstract

Disorders of cognition are a major societal burden. As the population grows and ages, these conditions demand urgent attention, as healthcare resources stretch to accommodate the growing number of patients. Although much is known about the neurobiology of dementia and Alzheimer's disease (AD), few treatments are available to arrest or slow down the illness. By targeting specific structures within known circuits, deep brain stimulation (DBS) can have effects across memory and cognitive networks, and is therefore a potentially promising avenue for novel dementia treatments. This chapter reviews the literature on DBS for AD and dementia associated with Parkinson's disease, and highlight some of the neuroanatomical targets that offer the most promise in modulating the underlying pathological activity in brain circuitry.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; deep brain stimulation; dementia; fornix; memory; neuromodulation; nucleus basalis of Meynert

Mesh:

Year:  2013        PMID: 24112904     DOI: 10.1016/B978-0-444-53497-2.00025-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  11 in total

Review 1.  Neurostimulation in Alzheimer's disease: from basic research to clinical applications.

Authors:  Raffaele Nardone; Yvonne Höller; Frediano Tezzon; Monica Christova; Kerstin Schwenker; Stefan Golaszewski; Eugen Trinka; Francesco Brigo
Journal:  Neurol Sci       Date:  2015-02-27       Impact factor: 3.307

2.  Response to deep brain stimulation in the lateral hypothalamic area in a rat model of obesity: in vivo assessment of brain glucose metabolism.

Authors:  María Luisa Soto-Montenegro; Javier Pascau; Manuel Desco
Journal:  Mol Imaging Biol       Date:  2014-06-06       Impact factor: 3.488

Review 3.  Clinical neuroprosthetics: Today and tomorrow.

Authors:  Morgan B Lee; Daniel R Kramer; Terrance Peng; Michael F Barbaro; Charles Y Liu; Spencer Kellis; Brian Lee
Journal:  J Clin Neurosci       Date:  2019-07-30       Impact factor: 1.961

Review 4.  Recent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment.

Authors:  Ferenc Deak; Willard M Freeman; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-11-20       Impact factor: 6.053

Review 5.  Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications.

Authors:  M P Dandekar; A J Fenoy; A F Carvalho; J C Soares; J Quevedo
Journal:  Mol Psychiatry       Date:  2018-02-27       Impact factor: 15.992

Review 6.  Closed-loop neurostimulation: the clinical experience.

Authors:  Felice T Sun; Martha J Morrell
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

7.  Forniceal deep brain stimulation rescues hippocampal memory in Rett syndrome mice.

Authors:  Shuang Hao; Bin Tang; Zhenyu Wu; Kerstin Ure; Yaling Sun; Huifang Tao; Yan Gao; Akash J Patel; Daniel J Curry; Rodney C Samaco; Huda Y Zoghbi; Jianrong Tang
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

8.  Compensatory neural mechanisms in cognitively unimpaired Parkinson disease.

Authors:  Kathleen L Poston; Sophie YorkWilliams; Kai Zhang; Weidong Cai; David Everling; Fadi M Tayim; Seoni Llanes; Vinod Menon
Journal:  Ann Neurol       Date:  2016-02-10       Impact factor: 10.422

Review 9.  What light have resting state fMRI studies shed on cognition and mood in Parkinson's disease?

Authors:  Sophie YorkWilliams; Kathleen L Poston
Journal:  J Clin Mov Disord       Date:  2014-10-29

Review 10.  Enhancing Nervous System Recovery through Neurobiologics, Neural Interface Training, and Neurorehabilitation.

Authors:  Max O Krucoff; Shervin Rahimpour; Marc W Slutzky; V Reggie Edgerton; Dennis A Turner
Journal:  Front Neurosci       Date:  2016-12-27       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.